US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 143.540
  • +3.870+2.77%
Trading Feb 26 10:34 ET
8.68BMarket Cap16.59P/E (TTM)

Jazz Pharmaceuticals Key Stats

Jazz Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
1.06B
1.09B
+30.06M
Beat Est.
+4.56%
+7.53%
+2.84%
EPS
2.71
3.11
+0.40
Beat Est.
+90.76%
+119.01%
+14.81%
Strong Buy

Feb 26, 2025

Jazz Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.056B--
--2025/Q1-- / 982.519M--
Feb 25, 20252024/Q41.088B / 1.058B--
Nov 6, 20242024/Q31.055B / 1.037B--
Jul 31, 20242024/Q21.024B / 1.004B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.056B--
--2025/Q1-- / 982.519M--
Feb 25, 20252024/Q41.088B / 1.058B--
Nov 6, 20242024/Q31.055B / 1.037B--
Jul 31, 20242024/Q21.024B / 1.004B--

Unlock Free Earnings Estimates

Jazz Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More